Senate HELP Committee Hearing on the USMCA
Senate Health, Education, Labor & Pensions (HELP) Committee
“Executive Session to Consider H.R. 5430, The United States-Mexico-Canada Agreement Implementation Act”
Wednesday, January 15, 2020
Bill Considered
Opening Statements
Chairman Lamar Alexander (R-Tenn.)
In his opening statement, Alexander outlined his support for the agreement, specifically praising the movement away from tariffs. He highlighted the fact that this agreement includes critical provisions to 1.) improve workers’ rights; 2.) strengthen the ability of American workers to compete on a level playing field; and 3.) codify enforcement authorities that will hold Mexico accountable in terms of workers’ rights.
Ranking Member Patty Murray (D-Wash.)
In her opening statement, Murray emphasized her belief that trade agreements can spur economic growth. Murray continued that while the United States-Mexico-Canada Agreement (USMCA) is not perfect, she is proud to support the agreement, specifically citing the labor enforcement provisions that will improve workers’ rights abroad. She concluded that while there is still more work to be done, the passage of this agreement is an important step in moving trading relations forward.
Member Statements
Sens. Tina Smith (D-Minn.) and Kelly Loeffler (R-Ga.) both spoke in favor of the agreement, outlining their belief that this agreement will provide relief and clarity for the American agricultural industry.
Sen. Bill Cassidy (R-La.) noted his concern regarding the dispute settlement remedies in this agreement. While he remains troubled with respect to dispute settlement, he praised United States Trade Representative (USTR) Robert Lighthizer for his engagement on this issue as well as the fact that the state-to-state resolution process has been strengthened. He concluded that he will support this agreement and that he is confident that President Trump will push back against any trade discrimination.
Sen. Mike Enzi (R-Wyo.) stated his support for the agreement but said he is disappointed protections for U.S. patents are not stronger, specifically referencing biologics.
The measure was reported favorably to the Senate by a vote of 22-1.
For more information on this hearing, please click here.
For an archive of past SIFMA hearing coverage, please click here.